SHEILA SWARTWOOD: Open Payments
NPI 1619332871 · AURORA, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,056 in 12 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $125 · 2025 $1,056
Food & beverage: $1,056
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 5 | $389 |
| Janssen Biotech, Inc. | 2 | $150 |
| Mirum Pharmaceuticals, Inc. | 1 | $145 |
| Amgen Inc. | 1 | $132 |
| Gilead Sciences, Inc. | 1 | $112 |
| Novo Nordisk Inc | 1 | $65 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $63 |
Products named: REZDIFFRA, TREMFYA, Livmarli, UPLIZNA, Livdelzi, Wegovy, LifeVest.
Industry payments across CO — which companies pay providers there.
